首页> 美国卫生研究院文献>Hepatitis Monthly >The Risk of Hepatocellular Carcinoma After Directly Acting Antivirals for Hepatitis C Virus Treatment in Liver Transplanted Patients: Is It Real?

【2h】

The Risk of Hepatocellular Carcinoma After Directly Acting Antivirals for Hepatitis C Virus Treatment in Liver Transplanted Patients: Is It Real?

机译：直接作用抗病毒药物治疗肝移植患者中丙型肝炎病毒后肝细胞癌的风险：是真的吗？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

IntroductionSince directly acting antivirals (DAAs) for treatment of hepatitis C virus (HCV) were introduced, conflicting data emerged about the risk of hepatocellular carcinoma (HCC) after interferon (IFN)-free treatments. We present a case of recurrent, extra-hepatic HCC in a liver-transplanted patient soon after successful treatment with DAAs, along with a short review of literature.

机译：简介由于引入了直接作用抗病毒药（DAA）来治疗丙型肝炎病毒（HCV），因此在无干扰素（IFN）治疗后出现肝细胞癌（HCC）风险的数据出现了矛盾。我们介绍了成功用DAA治疗后不久，肝移植患者复发，肝外HCC的病例，并简要回顾了文献。

著录项

期刊名称 Hepatitis Monthly
作者
Alessio Strazzulla; Rosa Maria Rita Iemmolo; Ennio Carbone; Maria Concetta Postorino; Maria Mazzitelli; Mario De Santis; Fabrizio Di Benedetto; Costanza Maria Cristiani; Chiara Costa; Vincenzo Pisani; Carlo Torti;
展开▼
作者单位

展开▼
年(卷),期 2016(16),11
年度 2016
页码 e41933
总页数 4
原文格式 PDF
正文语种
中图分类肠道病毒与肝炎病毒;肝及胆疾病;肠疾病;
关键词
Directly Acting Antivirals Hepatocellular Carcinoma Hepatitis C Virus Interferon Liver Transplant;

机译：直接作用抗病毒药;肝细胞癌;丙型肝炎病毒;干扰素;肝移植;

相似文献

外文文献
中文文献
专利

1. The Risk of Hepatocellular Carcinoma After Directly Acting Antivirals for Hepatitis C Virus Treatment in Liver Transplanted Patients: Is It Real? [J] . Alessio Strazzulla, Rosa Maria Rita Iemmolo, Ennio Carbone, Hepatitis Monthly . 2016,第11期

机译：直接作用抗病毒药物治疗肝移植患者中丙型肝炎病毒后肝细胞癌的风险：是真的吗？
2. Impact of Directly Acting Antivirals (DAAs) Treatment on Rates of Hepatocellular Carcinoma (HCC) in Hepatitis C Virus (HCV) and HIV Co-infected Patients [J] . Bari Shahla, Chan Austin, Olanipekun Titilope, The American Journal of Gastroenterology . 2018,第Suppla2期

机译：直接作用抗病毒药（DAAS）治疗对肝细胞癌（HCV）和HIV COR感染患者肝细胞癌（HCC）率的影响
3. Successful Treatment of Oral Lichen Planus with Direct-Acting Antiviral Agents after Liver Transplantation for Hepatitis C Virus-Associated Hepatocellular Carcinoma [J] . Maeshiro T, Kawahigashi Y, Nishida N, Case Reports in Gastroenterology . 2017,第3期

机译：丙型肝炎病毒相关肝细胞肝移植术后用直接作用抗病毒剂成功治疗口腔扁平苔藓
4. Herbal Medicine Containing Aristolochic Acid and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Infection: A Nationwide Population-Based Cohort Study in Taiwan [C] . Wen-Chao Ho, Chi-Jen Chen, Yao-Hsu Yang, Joint annual meeting of the International Society of Exposure Science and the International Society for Environmental Epidemiology . 2018

机译：含有马兜铃酸的草药和丙型肝炎病毒感染患者肝细胞癌的风险：台湾全国性人群研究
5. Healthcare Resources Utilization, Inpatient Mortality, and Risk Behaviors among Patients Infected with Hepatitis C Virus in the United States in the Era of Direct-Acting Antivirals [D] . Alzahrani, Mohammad Saeed. 2020

机译：在直接作用抗病毒中，美国乙型肝炎病毒感染患者的医疗资源利用率，住院死亡率和风险行为
6. Successful Treatment of Oral Lichen Planus with Direct-Acting Antiviral Agents after Liver Transplantation for Hepatitis C Virus-Associated Hepatocellular Carcinoma [O] . Yumiko Nagao, Kazunori Nakasone, Tatsuji Maeshiro, 2017

机译：丙型肝炎病毒相关肝细胞肝移植术后用直接作用抗病毒药物成功治疗口腔扁平苔藓
7. The Risk of Hepatocellular Carcinoma After Directly Acting Antivirals for Hepatitis C Virus Treatment in Liver Transplanted Patients: Is It Real? [O] . Alessio Strazzulla, Rosa Maria Rita Iemmolo, Ennio Carbone, 2016

机译：在肝脏移植患者中直接作用抗病毒后肝细胞癌的风险：是真的吗？

The Risk of Hepatocellular Carcinoma After Directly Acting Antivirals for Hepatitis C Virus Treatment in Liver Transplanted Patients: Is It Real?

摘要

著录项

相似文献

相关主题

期刊订阅